Published in Elder Law Weekly, July 7th, 2004
Under the terms of the agreement, Wampole will receive exclusive rights to distribute the NMP22 ELISA (Enzyme Linked Immunosorbent Assay) Test Kit to hospitals and clinical reference laboratories in the United States. Matritech's own sales force will continue to sell the NMP22 BladderChek Test directly to urologists in their offices.
"Wampole's proven ability to market and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.